ABOUT US
add
close
About Piramal
Leadership Team
History
Quality
Anti-capital punishment
FACILITIES
RESOURCES
add
close
Brochures
White Papers
Case Studies
Webinars
Videos
Blogs
NEWS & MEDIA
add
close
In The News
Press Releases
Awards
EVENTS
SUSTAINABILITY
PATIENT CENTRICITY
CAREERS
CONTACT US
Drug Discovery
add
close
Synthetic Chemistry
In Vitro Biology
Analytical Support Services
DMPK (In-Vitro ADME/ In-Vivo PK)
Non-GMP Kilo Lab Service
Drug Substance
add
close
API Development
Route Scouting
Process and analytical Development
Pre-GMP Scale-up
API Manufacturing
Pre-Clinical Supply
Clinical Supply
Commercial Supply
Scale-Up and Tech Transfer
Generic APIs
Product List
Special APIs Capabilities
High Potency API
Peptides
Hormonal API
Controlled Substances
Drug Product
add
close
Dosage Forms
Oral Solids
Liquids, Creams and Ointments
Sterile Injectable
Formulation Development
Pre-Formulation Studies
Analytical Development
Commercial Formulation Manufacturing
Clinical Supply
Scale Up Tech Transfer
Special Formulation Capabilities
Controlled Substances and Potent OSDs
Hormonal Formulations
Antibody Drug Conjugates
Specialized Offerings
add
close
Vaccines and Biologics
Peptides
Nutrition Solutions
add
close
Human Nutrition & Health
Vitamin Mineral Premix
Fortification Premix
Direct Vitamins
Customized Premix
Animal Nutrition & Health
Nicomix® - Vitamin Premix
Liquid Feed Supplements
Direct Vitamins
Custom Premixes & Formulations
Skincare
MaxReti® - Retinol and Diluted Forms
MaxReti® RP - Retinyl Palmitate
MaxReti ®-NAL - (all-trans-Retinaldehyde)
Food Programs
Micronutrient Premix
Therapeutic Nutrition
Staple Fortification
Vitamin A Oral Solution
Why Partner With Us?
add
close
Patient Centricity
Integrated Solution
Global Footprint
Science Collective
Customer Centricity
search
search
close
Should be more than 4 characters
search
search
close
Should be more than 4 characters
Knowledge Hub
Brochures
White Papers
Case Studies
Blogs
Videos
Webinars
Stu Needleman, CCO and Chief Patient Centricity Officer Explores How Our Expansion Benefits Patients
WATCH NOW
Understanding Our $85M Facility Expansion with COO, Herve Berdou
WATCH NOW
Breaking Ground on Our $85 Million Sterile Injectable Facility Expansion
WATCH NOW
Launching an $85M Expansion at Our Sterile Injectables Facility
WATCH NOW
Meet Jean-Francois Carniaux (JF), VP and Global API Technical Lead from our Science Collective
WATCH NOW
Meet Conor Barry, Global Head of Bioconjugates Development from our Science Collective
WATCH NOW
Meet Thomas B. (Brad) Gold, Ph.D.Head, Global Formulations R&D from our Science Collective
WATCH NOW
The Voice of Patient Centricity
WATCH NOW
Company Spotlight with Pharmaceutical Technology
WATCH NOW
PPS Transition to Differentiated Offerings and Value to the Customer
WATCH NOW
Piramal Pharma Solutions Capabilities Review
WATCH NOW
Piramal Pharma Solutions Program Management
WATCH NOW
PPS Transition to Integrated Projects and Value to the Customer
WATCH NOW
PPS Transition to On Patent Work and Value to the Customer
WATCH NOW
Piramal Pharma Solutions Position on East and West Offerings
WATCH NOW
Piramal Pharmas Associate Company Yapan Bio Pvt Ltd
WATCH NOW
Piramal Pharma Solutions Operational Excellence
WATCH NOW
Navigating Market Changes: Piramal Pharma's Growth and Key Industry Trends
WATCH NOW
Show More
Thank You for your Interest. Please enter your details.
Thank You for your Interest. Please enter your details.
Thank You for your Interest. Please enter your details.
.jpg)
.jpg)
.png)
.jpg)
.jpg)
.jpg)
.jpg)
